The Journal of Allergy and Clinical Immunology: In Practice
We appreciate the comments and perspective expressed by Dr. Strauss regarding our recent pandemic contingency guidance,1 and we agree that in the setting of acute severe asthma or impending respiratory failure, both nebulized albuterol and subcutaneous terbutaline are important clinical considerations. Although evidence suggests that inhaled albuterol through a metered dose inhaler can be as…